IMPLEMENTING GUIDELINES FOR MANAGING EXTRAVASATION OF ANTINEOPLASTICS

被引：11

作者：

HIRSH, JD

CONLON, PF

机构：

来源：

AMERICAN JOURNAL OF HOSPITAL PHARMACY | 1983年 / 40卷 / 09期

关键词：

D O I：

10.1093/ajhp/40.9.1516

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：1516 / 1519

页数：4

共 25 条

[1] NURSING MANAGEMENT OF ADRIAMYCIN EXTRAVASATION [J].

BARLOCK, AL ;

HOWSER, DM ;

HUBBARD, SM .

AMERICAN JOURNAL OF NURSING, 1979, 79 (01) :94-96

[2]

BELLONE JD, 1981, JAMA, V745, P343

[3] ADRIAMYCIN EXTRAVASATION [J].

BOWERS, DG ;

LYNCH, JB .

PLASTIC AND RECONSTRUCTIVE SURGERY, 1978, 61 (01) :86-92

[4]

COHEN MH, 1979, CANCER TREAT REP, V63, P1003

[5]

DORR RT, 1981, CANCER RES, V41, P2428

[6] THE LIMITED ROLE OF CORTICOSTEROIDS IN AMELIORATING EXPERIMENTAL DOXORUBICIN SKIN TOXICITY IN THE MOUSE [J].

DORR, RT ;

ALBERTS, DS ;

CHEN, HSG .

CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1980, 5 (01) :17-20

[7]

DORR RT, 1981, CANCER TREAT REP, V65, P1001

[8]

DORR RT, 1981, ARIZ MED, V38, P271

[9] THERAPY OF LOCAL TOXICITIES CAUSED BY EXTRAVASATION OF CANCER CHEMOTHERAPEUTIC DRUGS [J].

IGNOFFO, RJ ;

FRIEDMAN, MA .

CANCER TREATMENT REVIEWS, 1980, 7 (01) :17-27

[10]

LARSON DL, 1982, CANCER, V49, P1796, DOI 10.1002/1097-0142(19820501)49:9<1796::AID-CNCR2820490911>3.0.CO

← 1 2 3 →